相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Post-transplant CD34+selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series
Alexander Ngwube et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2022)
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease
Niketa C. Shah et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience
Friederike Kogel et al.
PEDIATRIC TRANSPLANTATION (2021)
Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion
Suzanne Verlhac et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Nonmyeloablative HLA-Identical Sibling Donor Transplantation for Children and Young Adults with Sickle Cell Disease: Interim Results of the SUN Multicenter Phase II Trial
Robert Sheppard Nickel et al.
BLOOD (2021)
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres
Mohsen Alzahrani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some Controls
Amandine Remy et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)
Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide
Lisa V. E. Oostenbrink et al.
BONE MARROW TRANSPLANTATION (2021)
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation
Julie Kanter et al.
Blood Advances (2021)
Indirect Economic Burden of Sickle Cell Disease
David Holdford et al.
VALUE IN HEALTH (2021)
Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation
Stephen P. Persaud et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France
Francoise Bernaudin et al.
HAEMATOLOGICA (2020)
Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy
Alessandra Magnani et al.
HAEMATOLOGICA (2020)
Fertility Concerns and Access to Care for Stem Cell Transplantation Candidates with Sickle Cell Disease
Adrienne D. Mishkin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in Europe
Eliane Gluckman et al.
BONE MARROW TRANSPLANTATION (2020)
Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies
Seung-Hwan Shin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review
Soyon Lee et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2020)
Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017
Amanda B. Payne et al.
ANNALS OF EMERGENCY MEDICINE (2020)
Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation
Sasia J. Pedersen et al.
PEDIATRIC BLOOD & CANCER (2020)
Timing of Alemtuzumab With Respect to Day of Bone Marrow Infusion and its Effects Upon Engraftment and Graft-Versus-Host Disease in Patients With Sickle Cell Disease: A Single-Institutional Study
Indira Sahdev et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2020)
Nonmyeloablative Matched Sibling Donor Hematopoietic Cell Transplantation in Children and Adolescents with Sickle Cell Disease
Gregory M. T. Guilcher et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease
Juergen Foell et al.
BONE MARROW TRANSPLANTATION (2019)
Adolescent male fertility following reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in non-malignant disorders
Jun Zhao et al.
PEDIATRIC TRANSPLANTATION (2019)
Busulfan-Induced Lung Injury in Pediatric Oncology Patients-Review of the Literature with an Illustrative Case
Nusa Matijasic et al.
PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY (2019)
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study
Mary Eapen et al.
LANCET HAEMATOLOGY (2019)
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study
Lakshmanan Krishnamurti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative
Josu de la Fuente et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Outcomes of Unrelated Donor Stem Cell Transplantion with Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients with Severe Sickle Cell Disease
Hemalatha G. Rangarajan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease
Anna B. Pawlowska et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment
Yasuyuki Arai et al.
MOLECULAR THERAPY (2018)
Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease
Gregory M. T. Guilcher et al.
SEMINARS IN HEMATOLOGY (2018)
Risks associated with fertility preservation for women with sickle cell anemia
Lydia H. Pecker et al.
FERTILITY AND STERILITY (2018)
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
Eliane Gluckman et al.
BLOOD (2017)
Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe
Poulami Maitra et al.
HAEMATOLOGICA (2017)
Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review
Michelle Matthews et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2017)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe
Poulami Maitra et al.
HAEMATOLOGICA (2017)
Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease
Antonio Marzollo et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2017)
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease
Allistair Abraham et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT
Courtney D. Fitzhugh et al.
BLOOD (2017)
Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial
Allistair Abraham et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Alternative donor hematopoietic stem cell transplantation for sickle cell disease
Andrew L. Gilman et al.
BLOOD ADVANCES (2017)
Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
Volker Wiebking et al.
ANNALS OF HEMATOLOGY (2017)
European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies
Heidrun Boztug et al.
PEDIATRIC BLOOD & CANCER (2016)
Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease
Santosh L. Saraf et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease
Shalini Shenoy et al.
BLOOD (2016)
Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin
Rahul Palchaudhuri et al.
NATURE BIOTECHNOLOGY (2016)
Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies
Feras Alfraih et al.
SEMINARS IN HEMATOLOGY (2016)
Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies
Allison A. King et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial
John T. Horan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases
M. A. Slatter et al.
BONE MARROW TRANSPLANTATION (2015)
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease
Luisa Strocchio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
New Insights Into the Pharmacokinetics of Intravenous Busulfan in Children With Sickle Cell Anemia Undergoing Bone Marrow Transplantation
Javid Gaziev et al.
PEDIATRIC BLOOD & CANCER (2015)
Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood
Simon Bomken et al.
CHILDREN-BASEL (2015)
Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies Using a Reduced-Intensity Conditioning Regimen and Third-Party Mesenchymal Stromal Cells
Sandhya Kharbanda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Targeted Busulfan therapy with a steady-state concentration of 600-700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant
S. Maheshwari et al.
BONE MARROW TRANSPLANTATION (2014)
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease
M. Bhatia et al.
BONE MARROW TRANSPLANTATION (2014)
Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients
Laurence Dedeken et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
Matthew M. Hsieh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom
Mark T. Gladwin et al.
PLOS ONE (2014)
Induction of Tolerance through Mixed Chimerism
David H. Sachs et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Long-Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease
Mari H. Dallas et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Stem cell transplantation after reduced-intensity conditioning for sickle cell disease
Susanne Matthes-Martin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Normalized Transcranial Doppler Velocities, Stroke Prevention and Improved Pulmonary Function after Stem Cell Transplantation in Children with Sickle Cell Anemia
M. Mynarek et al.
KLINISCHE PADIATRIE (2013)
An Educational Symposium for Patients With Sickle Cell Disease and Their Families: Results From Surveys of Knowledge and Factors Influencing Decisions About Hematopoietic Stem Cell Transplant
Amanda L. Thompson et al.
PEDIATRIC BLOOD & CANCER (2013)
Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
Naynesh R. Kamani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions
Eileen N. Hansbury et al.
PEDIATRIC BLOOD & CANCER (2012)
Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease
M. E. McPherson et al.
BONE MARROW TRANSPLANTATION (2011)
Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience
S. Majumdar et al.
BONE MARROW TRANSPLANTATION (2010)
Toxicity of Chemotherapy and Radiation on Female Reproduction
Dror Meirow et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease
Lakshmanan Krishnamurti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS
Borje S. Andersson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Donor/recipient mixed chimerism does not predict graft failure in children with β-thalassemia given an allogeneic cord blood transplantation from an HLA-identical sibling
Daniela Lisini et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Francoise Bernaudin et al.
BLOOD (2007)
The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia
Giorgio La Nasa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Children with sickle cell disease: Growth and gonadal function after hematopoietic stem cell transplantation
Cecile Brachet et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2007)
Myeloablative and immunosuppressive properties of treosulfan in mice
F Sjoo et al.
EXPERIMENTAL HEMATOLOGY (2006)
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin
JT Horan et al.
BONE MARROW TRANSPLANTATION (2005)
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
R Diaconescu et al.
BLOOD (2004)
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia
R Iannone et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
F Locatelli et al.
BLOOD (2003)
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
MC Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease
AM Bolinger et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
